Large-scale testing (Phase 3)Active Not RecruitingNCT06082167
What this trial is testing
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Who this might be right for
Head and Neck Squamous Cell Carcinoma
Exelixis 600